Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) is now available.
WuXi AppTec has voluntarily released a full presentation of its first-quarter 2026 financial results and business operations to give shareholders and potential investors a more comprehensive view of its performance. The company cautions that the materials may include estimates and other information subject to risks and uncertainties, and advises investors to exercise care and avoid placing undue reliance on the presentation when dealing in its securities.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$150.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a China-incorporated joint stock company listed in Hong Kong that operates in the life sciences and pharmaceutical services industry. The company provides research, development and manufacturing support to global pharmaceutical and biotech customers, positioning itself as an integrated platform player in the contract research and development market.
Average Trading Volume: 4,880,283
Technical Sentiment Signal: Buy
Current Market Cap: HK$342B
Learn more about 2359 stock on TipRanks’ Stock Analysis page.